Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 151 for Amyloidosis

Edit search filters
  1. Venetoclax-Dexamethasone In Relapsed And/or Refractory T(11;14) Amyloidosis

    Rochester, MN

  2. Artificial Intelligence Enhanced ECG To Detect Cardiac Amyloidosis

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, Rochester, MN

  3. Diagnostic Utility Of F-18 Florbetapir PET/MR In Peripheral Nerve Amyloidosis

    Rochester, MN

  4. TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Rochester, MN

  5. Study Of Dexamethasone Plus IXAZOMIB Or Physician's Choice Of Treatment In Relapsed Or Refractory Systemic Light Chain (AL) Amyloidosis

    Rochester, MN

  6. A Study Of PRX004 In Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

    Rochester, MN

  7. APOLLO: The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis

    Rochester, MN

  8. A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

    Jacksonville, FL

  9. Phase 1/2, Open Label, Dose Escalation Study Of NEOD001 In Subjects With Light Chain (AL) Amyloidosis

    Rochester, MN

  10. An Extension Study To Evaluate The Long-Term Safety And Tolerability Of NEOD001 For Treatment Of People With Light Chain Amyloidosis

    Rochester, MN

.

Mayo Clinic Footer